IPO Trending
AGARWALEYEEQ / NSE, BSEListed

Dr. Agarwals Health Care Limited

Dr. Agarwal’s Health Care Limited, founded on April 19, 2010, is a leading eye care provider in India. Based in Chennai, Tamil Nadu, the company runs one of the largest networks of eye hospitals both in India and internationally. They specialize in advanced eye care services like cataract surgeries, retinal treatments, refractive surgeries, corneal transplants, glaucoma management, and pediatric eye care. Known for using the latest technologies and innovative surgical methods, the company is trusted by patients for its high-quality care. Dr. Agarwal’s also offers customized treatments for complex eye conditions and has a team of highly skilled ophthalmologists and staff to ensure the best results. They are committed to constantly improving by investing in new medical technologies and training programs. As of March 31, 2024, the company has expanded globally and employs over 1,000 professionals, including doctors, researchers, and administrative staff, all working towards making top-notch eye care accessible and affordable for everyone.

₹382 - ₹4021.55x sub
Listed Price402.00
Listing Gain+0.00%
TimelineBook Built Issue IPO
Open29 Jan 2025
Close31 Jan 2025
Allotment01 Feb 2025
Listing04 Feb 2025

Quota Reservation Portions

RetailPortion: 2,54,08,599 shares
33.74%
Nii(hni)Portion: 1,08,89,400 shares
14.46%
QIBPortion: 1,45,19,200 shares
19.28%
ShareholdersPortion: 11,29,574 shares
1.5%
EmployeesPortion: 15,79,399 shares
2.1%

Minimum Application Bracket Matrix

Retail1 lots / 35 shares
₹14,070
sHNI15 lots / 525 shares
₹2,11,050
bHNI15 lots / 525 shares
₹2,11,050

About the Company

Dr. Agarwal’s Health Care Limited, founded on April 19, 2010, is a leading eye care provider in India. Based in Chennai, Tamil Nadu, the company runs one of the largest networks of eye hospitals both in India and internationally. They specialize in advanced eye care services like cataract surgeries, retinal treatments, refractive surgeries, corneal transplants, glaucoma management, and pediatric eye care. Known for using the latest technologies and innovative surgical methods, the company is trusted by patients for its high-quality care. Dr. Agarwal’s also offers customized treatments for complex eye conditions and has a team of highly skilled ophthalmologists and staff to ensure the best results. They are committed to constantly improving by investing in new medical technologies and training programs. As of March 31, 2024, the company has expanded globally and employs over 1,000 professionals, including doctors, researchers, and administrative staff, all working towards making top-notch eye care accessible and affordable for everyone.

Company Promoters

Dr. Amar AgarwalDr. Athiya AgarwalDr Adil AgarwalDr. Anosh AgarwalDr Ashvin AgarwalDr. Ashar Agarwal Dr. Amar Agarwal Family Trust Dr Adil Agarwal Family TrustDr. Anosh Agarwal Family TrustDr Ashvin Agarwal Family TrustDr. Ashar Agarwal Family TrustDr Agarwal’s Eye InstituteDr Agarwal's Eye Institute Private Limited
Dr. Agarwals Health Care Limited IPO Details | GMP, Allotment & Financials | IPO Trending